SEC Form 4 · accession 0001225208-16-042548
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kieran Gallahue
Director
Period of report
Nov 29, 2016
Accepted (ET)
Dec 1, 2016 · 7:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 29, 2016 | P | 3,000 | $84.6334 | A | 6,042 | I | By Trust |
| Common StockF2 | holding | — | — | — | 2,524 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $84.38 to $84.98. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2Reflects a difference of 3,042 shares which were previously reported as directly held by the Reporting Person but are held by Trust. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.